TTNP insider filings

TITAN PHARMACEUTICALS INC — 30 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-10-08. Screen TTNP transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TTNP between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — TITAN PHARMACEUTICALS INC

FiledFormInsiderReported transactionsSource
2025-10-084Ben-Tzvi Avraham — DirectorDisposition to issuer (D): 3,313 · Disposition to issuer (D): 1,250 (derivative) · Disposition to issuer (D): 5,000 (derivative)EDGAR
2024-03-274Choong Choon Hau — 10% ownerConversion (C): 54,132 @ $0 · Conversion (C) @ $0EDGAR
2023-10-264Ben-Tzvi Avraham — DirectorGrant/award (A): 16,250 @ $0EDGAR
2023-10-264Greenberg Eric Howard — DirectorGrant/award (A): 16,250 @ $0EDGAR
2023-10-264McMurdo Matthew Charles — DirectorGrant/award (A): 16,250 @ $0EDGAR
2023-10-264Beebe Katherine — President and COO, DirectorGrant/award (A): 16,250 @ $0EDGAR
2023-10-264NATAN DAVID — DirectorGrant/award (A): 16,250 @ $0EDGAR
2023-07-314Ben-Tzvi Avraham — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-314Greenberg Eric Howard — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-314/AChasey Peter Louis — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-314/AMcMurdo Matthew Charles — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-314Lazar David E. — Chief Executive Officer, DirectorGrant/award (A): 100,000 @ $0EDGAR
2023-07-314/ANATAN DAVID — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-284Chasey Peter Louis — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-284McMurdo Matthew Charles — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-284Beebe Katherine — President and COO, DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-07-284NATAN DAVID — DirectorGrant/award (A): 50,000 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-06-284/ALazar David E. — Chief Executive Officer, Director, 10% owner
Activist Investing LLC
Sale (S): 3,388,902 @ $1.23 · Sale (S): 359,066 @ $1.23EDGAR
2023-06-234Lazar David E. — Chief Executive Officer, Director, 10% owner
Activist Investing LLC
Sale (S): 3,388,902 @ $1.23 · Sale (S): 359,066 @ $1.23EDGAR
2023-01-264Lazar David E. — Chief Executive Officer, Director, 10% owner
Activist Investing LLC
Purchase (P): 37,500 @ $0.97 · Purchase (P): 20,000 @ $1.00EDGAR
2022-07-084Lazar David E. — 10% owner
Activist Investing LLC
Purchase (P): 1,165,975 @ $0.77 · Purchase (P): 744,294 @ $0.99 · Purchase (P): 315,921 @ $0.89EDGAR
2022-01-284MCNAB JAMES R — DirectorOther (J): 51,021EDGAR
2022-01-054Beebe Katherine — President and COO, DirectorGrant/award (A): 55,000 (derivative) @ $0EDGAR
2022-01-054Rubin Marc — Executive Chairman, DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-01-054Akers Joseph A — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-01-054MCNAB JAMES R — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-114Beebe Katherine — President and COO, DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-02-114Rubin Marc — Executive Chairman, DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-02-114Akers Joseph A — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-02-114MCNAB JAMES R — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR

Recent 8-K events — TITAN PHARMACEUTICALS INC

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-10-018-K2.01 — Completion of Acquisition or Disposition of Assets
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-268-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-278-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-188-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-038-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-028-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-228-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-04-018-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.02 — Unregistered Sales of Equity Securities
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-088-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-068-K4.01 — Changes in Registrant's Certifying Accountant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TTNP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs